Sort
51,593 grants matching “hepatitis”
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$823,351Susan R. Weiss · University Of Pennsylvania · R01 · FY2019 · AI
Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection
$823,218Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2020 · AG
Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis
$823,071Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2011 · CA
Indiana University Center for Pediatric Pharmacology and Precision Medicine
$823,069Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2016 · HD
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$822,959Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2023 · NS
The UCLA Center in Early Detection of Liver Cancer
$822,938Xianghong Jasmine Zhou · University Of California Los Angeles · U01 · FY2024 · CA
Ectopic Fat, Adipocytokines, and Atherosclerosis in Postmenopausal Women
$822,859Rachel P Wildman · Albert Einstein College Of Medicine · R01 · FY2009 · HL
Innate immunity and cytokines in liver disease
$822,841Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
Immune response dynamics and hepatitis B cure in persons with and without HIV infection
$822,835Justin Richard Bailey · Johns Hopkins University · U19 · FY2025 · AI
Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH
$822,489Andrea L Cox · Johns Hopkins University · R01 · FY2025 · AI
Role of antibodies in hepatitis E virus infection
$822,317Zongdi Feng · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · AI
Role of antibodies in hepatitis E virus infection
$822,317Zongdi Feng · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
First-in-human study of a potent anti-HBsAg neutralizing antibody
$822,075Marina Caskey · Rockefeller University · U01 · FY2025 · AI
Novel Statistical Methods for Confounded and Incomplete Network Data
$822,015Eric J Tchetgen · University Of Pennsylvania · R56 · FY2025 · AI
Genetic Modifiers of Liver Disease Severity in Alagille Syndrome
$821,952Nancy Bettina Spinner · Children'S Hosp Of Philadelphia · R01 · FY2011 · DK
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$821,911Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2024 · NS
Metabolic effects and mechanisms for heart failure in South Asians
$821,729Alka M Kanaya · University Of California, San Francisco · R01 · FY2025 · HL
Hepatitis C: Studies of Immunity and Pathogenesis
$821,545Charles M. Rice · Rockefeller University · U19 · FY2009 · AI
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study (NHLBI Supplement)
$821,012Stephen John Gange · Johns Hopkins University · U01 · FY2019 · HL
Developing Woodchucks Susceptible to Hepatitis B Virus Infection by Modifying the Virus or Host
$820,940Stephan Menne · Georgetown University · R01 · FY2024 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$820,861Justin Richard Bailey · Johns Hopkins University · R01 · FY2023 · AI
Control of Cholesterol Metabolism --Bile Acid Transport
$820,465John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2008 · HL
Outcomes of non-vitamin K anticoagulants in atrial fibrillation
$820,409Wayne A Ray · Vanderbilt University Medical Center · R01 · FY2022 · HL
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
$820,384Andrea L Cox · Johns Hopkins University · U19 · FY2023 · AI
Molecular Roles of TGF-beta Signaling in Salivary Glands and Oral Cancer
$820,320Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE